Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre

Archives of Disease in Childhood

Volumn 96, Issue 12, 2011, Pages 1118-1123

  Dijk, F Nicole ^a,b   McKay, Karen ^a,c   Barzi, Federica ^a   Gaskin, Kevin J ^c   Fitzgerald, Dominic A ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DEATH; FORCED EXPIRATORY VOLUME; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN; NEWBORN SCREENING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SURVIVAL;

AGE FACTORS; ANTHROPOMETRY; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CYSTIC FIBROSIS; EARLY DIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NEW SOUTH WALES; NUTRITIONAL STATUS; OPPORTUNISTIC INFECTIONS; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MECHANICS; SPIROMETRY; SPUTUM; SURVIVAL ANALYSIS;

EID: 81255208482     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300449     Document Type: Article

References (21)

1. Waters DL, Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F1-7. (Pubitemid 29129589)
2. McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales. J Pediatr 2005;147:S47-50. (Pubitemid 41400259)
3. WHO: Annex 3: reference data for the weight and height of children. In: Measuring Change in Nutritional Status: Guidelines for Assessing the Nutritional Impact of Supplementary Feeding Programs for Vulnerable Groups. Geneva: World Health Organization 1983:61-101.
4. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1110-36.
5. Polgar GE, Promadhad V. Pulmonary Function Testing in Children: Techniques and Standards.Philadelphia, PA: WB Saunders 1971:88-107.
6. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child 1958;96:6-15.
7. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995;50:712-8.
8. Mérelle ME, Schouten JP, Gerritsen J, et al. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-15. (Pubitemid 32776406)
9. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991;66:29-33.
10. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997;337:963-39.
11. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001;107:1-13. (Pubitemid 32055408)
12. Mastella G, Zanolla L, Castellani C, et al. Neonatal screening for cystic fibrosis: long-term clinical balance. Pancreatology 2001;1:531-7. (Pubitemid 33681756)
13. Accurso FJ, Sontag MK, Wagener JS. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr 2005;147:S37-41. (Pubitemid 41400257)
14. Siret D, Bretaudeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 2003;35:342-9. (Pubitemid 36529972)
15. Sims EJ, Clark A, McCormick J, et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007;119:19-28. (Pubitemid 46397838)
16. Konstan MW, Butler SM, Wohl ME, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624-30. (Pubitemid 36737164)
17. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002;57:596-601. (Pubitemid 34761761)
18. Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100:E2.
19. Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003;168:1100-8. (Pubitemid 37338940)
20. Farrell PM, Kosorok MR, Rock MJ et al. Lung disease in patients with cystic fibrosis diagnosed through neonatal screening or after delays associated with traditional methods (abstract). Pediatr Pulmonol 2002;24:319S.
21. Wang SS, FitzSimmons SC, O'Leary LA, et al. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study. Pediatrics 2001;107:274-9. (Pubitemid 32121241)